NEW YORK (GenomeWeb News) – Roche today reported that its molecular diagnostics sales rose 5 percent and its applied science revenues increased 8 percent year over year for the first half of 2009.

The Swiss pharmaceuticals, diagnostics, and life sciences firm reported molecular diagnostic sales of CHF594 million (US$553.8 million), up 5 percent, while its applied science business brought in revenues of CHF 403 million, an increase of 8 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.